Clinical Trials in Detroit

Showing 19081-19100 of 19,719 trials

Study Evaluating rFIX; BeneFIX® in Hemophilia B

NCT00093171

The primary objective of this clinical research study is to assess the safety and efficacy of rFIX for a minimum of 6 months in previously treated patients (PTPs) with hemophilia B (FIX:C ≤2%) during standard-of-care treatment (on-demand, prophylaxis, and through major and minor surgical procedures).

Hemophilia B

Wyeth is now a wholly owned subsidiary of Pfizer23 participants

Los Angeles, California, United States • Aurora, Colorado, United States • Detroit, Michigan, United States +4 more locations

COMPLETEDNA12 miles

The RETRIEVE Study: Use of the FiberNet® Embolic Protection System in Saphenous Vein Grafts

NCT00453518

This is a multicenter, prospective study designed to demonstrate the performance and safety of the FiberNet Embolic Protection System when used as an adjunctive device during saphenous vein graft (SVG) intervention.

Saphenous Vein Graft DiseaseMyocardial IschemiaEmbolism

Lumen Biomedical29 participantsStarted Mar 2007

Ocala, Florida, United States • Indianapolis, Indiana, United States • Royal Oak, Michigan, United States +3 more locations

COMPLETEDEARLY Phase 190 miles

A Multicenter Study to Assess the Effect of Plasma Exchange in Accelerating the Clearance of Natalizumab in Subjects With Multiple Sclerosis (MS)

NCT00424788

Natalizumab (TYSABRI) is a protein-based drug that is manufactured by Biogen Idec in partnership with Elan Pharmaceuticals. Natalizumab is approved in the US and Europe for the treatment of Multiple Sclerosis (MS). The purpose of this study is to determine whether the amount of natalizumab (TYSABRI) that is present in your blood (plasma) can be reduced or eliminated by separating and removing the plasma and replacing it with other fluids, a process called plasma exchange.

Relapsing Forms of Multiple Sclerosis

Biogen12 participantsStarted Jan 2007

Cleveland, Ohio, United States • Milwaukee, Wisconsin, United States

Study Evaluating rFIX; BeneFIX® in Hemophilia B

The RETRIEVE Study: Use of the FiberNet® Embolic Protection System in Saphenous Vein Grafts

A Multicenter Study to Assess the Effect of Plasma Exchange in Accelerating the Clearance of Natalizumab in Subjects With Multiple Sclerosis (MS)

Find Trials by Condition in Detroit

Evaluation of Neutrophil Gelatinase-associated Lipocalin (NGAL) in Early and Evolving Acute Kidney Injury

A Phase 2a Study to Evaluate the Safety, Tolerability, Pharmacodynamics and Efficacy of AG011 in Ulcerative Colitis

REGENESIS (CA): A Study of NTx™-265: Human Chorionic Gonadotropin (hCG) and Epoetin Alfa (EPO) in Acute Ischemic Stroke Patients

Efficacy and Safety Study of SLC022 in Treating Pain Associated With Post Herpetic Neuralgia

A Study of BMS-663513 Administered in Combination With Chemotherapy to Subjects With Advanced Solid Malignancies

A New Formulation of Calcitriol (DN-101) in Patients With Advanced Malignancies

A Study of the Effects of 6R-BH4 on Blood Pressure in Subjects With Poorly Controlled Systemic Hypertension

A Phase 3, Multicenter, Open-Label Extension Study of Phenoptin in Subjects With PKU Who Have Elevated Phenylalanine Levels

Duloxetine Versus Placebo for Osteoarthritis Knee Pain

Study of Intra-articular Delivery of tgAAC94 in Inflammatory Arthritis Subjects

A Study Of 6-Month Duration To Evaluate The Weight Loss Effect Of Various Doses Of CP-945,598 In Obese Subjects

Duloxetine Versus Placebo in the Prevention of Recurrence of Major Depressive Disorder

Oral NRX 194204 Study in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)

Duloxetine vs. Placebo in the Treatment of Osteoarthritis Knee Pain

Kronos Early Estrogen Prevention Study (KEEPS)

Plaquenil for Alopecia Areata, Alopecia Totalis

Multiple Dose Escalation Trial Of PF-04603629 Given To Subjects With Type 2 Diabetes Mellitus